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The activation of the precarcinogen

2-aminoanthracene

was investigated employing cell-free extracts of Escherichia
coil, Pseudomonas aeruginosa, Streptococcus faecalis,
Bacteroides fragilis, Clostridium aerfrinc7ens and the
eukaryote Candida albicans.

A modification of the Salmonella

typhimurium/mammalian microsomal mutagenicity assay was
employed to determine activation.

Of the species tested,

only cell-free extracts of Escherichia coli and Bacteroides
fragilis failed to induce the reversion of the Salmonella
t12himurium his- mutailts TA-98 and/or TA-100 to his+
revertants.
Separation of the cytosol and membrane pellet enzymes
was completed.

Of the organisms tested only the membrane

pellet enzymes of Clostridium perfringens showed activation
of 2-aminoanthracene.

viii

INTRODUCTION
The original Ames assay (Salmonella/microsome mediated
mutagenicity test) was developed to screen large numbers of
existing and novel compounds for mutagenicity and carcinogenicity in a technically simple, relatively rapid, and cost
effective way (Ames et al. 1975b).

McCann et al. (1975b)

tested 300 chemicals and demonstrated that the lanes assay
system was at least 90% effective in screening chemicals
correctly for their mutagenic/carcinogenic properties.

The

Ames mutagenicity test has been well characterized and widely
applied to detect environmental mutagens and carcinogens because of its simplicity, sensitivity, and accurary (McCann
et al. 1975a; McCann et al. 1975c; DeSeves 1976; Grant et al.
1976; Ashwood-Smith 1977; Neeman et al. 1980; Sinha and
Parulekar 1983).

There is concern, however, that genetic

tests in microorganisms with liver microsomal enzyme preparations may not be sufficient in all situations to accurately
predict the potential genetic activity of a compound for
humans (Coohill and Moore, [1983]).
An important aspect of the Ames test is that the system
incorporates mammalian mierosomal enzymes to activate the
precarcinogens to their mutagenie potentials thus indicating
that similar activation is possible in vivo as well as the
in vitro system used.

In early testing with the Ames assay,

only mammalian enzymes were used because the presence in

2

bacterial systems of enzymes necessary for the activation
of precarcinoqens had not been established (Ames et al.
With the increasing understanding of the metabolic
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pathways for the activation of certain chemicals, new
questions arose concerning the demand for strictly mammalian
tissue enzymes.

A specifically pertinent question was

whether or not the intestinal microflora could indeed contain
sufficient enzymes to activate chemicals consumed in a
normal diet.
Precarcinogens have been demonstrated that could be
activated by mammalian systems to their mutaqenic potential.
Activated carcinogens were isolated from the urine of mice,
and the urine demonstrated a positive response in the Ames
assay (Bos et al. 1980), but work was still proceeding in
the area of colon enzyme activation.

Tamura et al. (1980)

clearly showed that "fecalases" (cell-free extract of human
feces) could be used to activate dietary glycosides to
mutagens.

This finding was a step forward in the search for

the etiology of colon cancer.

The research suggested that

glycosides are activated to a mutagenic form by mixed
enzymes from fecal bacteria.
The present thesis investigation was conducted to
determine if (1) "fecalases" might be enzymes from microorganisms indigenous to the human colon or from pathogens
in
of the colon and (2) if the enzymes isolated were located
that
the cytosol or membrane of the particular microorganism
had been shown to be active in causing chemicals to produce
mutagenic changes in the Ames test.

MATERIALS AND METHODS

Strains and Their Maintenance
Salmonella typhimurium TA-98 and TA-100 were the two
bacterial tester strains used in the Ames assay.

S.

typhimurium TA-98 detects frameshift mutagens and TA-100
detects both base substitution mutagens and frameshift
mutagens.

The cultures were obtained from Dr. L.K.

Nakamura, Agricultural Research Center, Peoria, IL

61604.

The two strains were received in the lypholized state and
were activated by growing in Brain Heart Infusion broth
(Difco Laboratories) at 37°C for 18-24 h.

The enteric

microorganisms used were Escherichia coli ATCC 25922,
Pseudomonas aeruginosa ATCC 27853, Streptococcus faecalis
(Western Kentucky University stock culture), Bacteroides
fragilis (isolated from a human abdominal abcess at Greenview
Hospital, Ashley Circle, Bowling Green, KY

42101), Clostridium

perfringens #2 (Western Kentucky University stock culture),
and the pathogenic yeast Candida albicans (Western Kentucky
University stock culture).
Stock cultures of the above aerobic bacteria and Candida
albicans were made on Nutrient Agar (Difco) slants and grown
for 48 h at 37°C before storing as stocks or using as an
inoculum in experiments.

Clostridium perfringens and

Bacteroides fragilis were grown in Thioglycollate Broth
(Difco) at 37°C for 24-48 h before storing as stocks or using
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as an inoculum in expeiiments.

All cultures were stored at

refrigeration temperature when not in use.
All above rrentioned cultures were transferred to fresh
media

and incubated at 37°C for 24-48 h monthly to main-

tain viable culture material.

Bacterial Indicator Strains
The genetic properties and spontaneous mutability of
the auxotrophic indicator strains of Salmonella typhimurium
were routinely checked as described by Ames et al. (1975).
To obtain stock and working cultures of the two indicator
strains, the lypholized culture material was inoculated into
BHI broth (24 ml) and incubated for 6 h at 37°C.

These

cultures were then used to inoculated 75 ml of BHI broth
contained in a side-arm flask.

These flasks were incubated

at 37°C for 12 h in a reciprocal shaker by shaking at 100
oscillations per minute in a New Brunswick Scientific
Controlled Environmental Incubator Shaker.

From these

cultures 5 ml were pipetted into each of three sterile
screw-cap test tubes for each strain for storage as stock
cultures by pipetting 1.1 ml into 5-ml screw-cap vials, and
both stock and working cultures were stored at -70°C.
When required, the working cultures were removed from
the freezer, warmed to room temperature and allowed to stand
at room temperature for 30 to 60 minutes.

At that time,

1.0 ml of the warmed culture was inoculated into 25 ml of
BHI broth

and subsequently incubated at 37°C for 12 to 24 h

in a shaker incubator until dense growth was obtained.

The
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resulting culture was then used as the broth culture in the
assay system explained later in this section.
To prepare additional working cultures, the stock
culture was removed from the -70°C freezer, and a few ice
crystals were removed using a small sterile Pasteur pipette.
These ice crystals were transferred into 25 ml of BHI broth
and incubated at 37° C until dense growth occurred.

For

Salmonella typhmurium TA-98 growth usually occurred within
16-18 h and for Salmonella typhmurium TA-100 the incubation
period was usually 24 to 30 h.

These cultures were then

used as an inoculum for 75 ml of Bill broth in a side-arm
culture flask.

The culture flasks were then incubated at

37°C for 12 h in a shaker incubator.

The resulting dense

cultures were pipetted in 1.1 ml aliquots into 5.0 ml
screw-cap vials and then frozen as previously mentioned.

Liver Homogenates (S-9)
The liver homogenates were prepared from male BALB/c
mice stimulated with AROCLOR 1254 (500 mg/kg intraperitoneal
injection five days before sacrifice).

The livers were placed

in preweighed, chilled, glass beakers containing 0.15 M KC1.
After weighing, the livers were minced with sterile iris
scissors.

Next, 3 ml of cold 0.15 M KC1 were added to the

beaker for each gram of wet liver.

This mixture was

homogenized in a manual homogenizer maintained at a
temperature of 0-4°C in an ice bath.
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Atte

Lne above had been accomplished, the homogenized

been
liquid was decanted into centrifuge tubes that had
previously cooled at 0-4'C.

The material was then centri-

Automatic RB-2
fuged at 9,000 x g for 10 xinutes in a Sorvall
refrigerated centrifuge at 0-4°C.

The resulting supernatant

test
was carefully decanted into sterile 10 ml screw-cap
-70°C until
tubes in 2 ml aliquots which were then stored at
utilized.

The protein concentration of each extract was

and
determined by the Waddel method as described by Murphy
Kies (1960).

Microbial Homogenates (S-13)
Preparation of the bacterial enzyme solution was
containing 25 ml
initiated by inoculating several test tubes
ichia coli,
of BHI broth from the working cultures of Escher
and Candida
Pseudomonas aeruginosa, Streptococcus faecalis,
albicans.
at 37°C.

h)
These were then incubated overnight (16 to 18
ate
The incubated cultures were then used to inocul

250 ml of BHI Broth in 1-L screw-cap flasks.

The ratio of

inoculum to broth was 1:10.
e for
The above flasks were incubated in a shaker cultur
12 to 18 h at 37°C.

At this time, the cultures were removed

from the incubator and cooled at 0-4°C.

These cooled cultures

were then centrifuged at 5,000 x q for 10 minutes.

The super-

ded in 30natant was decanted, and the pellet was re-suspen
above con50 ml of 0.15 M KCI and recentrifuged under the
ditions.

cells
This procedure was repeated to ensure that the

were free of the growth medium.

The wet weight of the cells
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was then obtained and 3 ml of the 0.15 M KC1 solution were
used to re-suspend each gram of cells.
The cells were disrupted by sonification.

Sonification

was performed with a Sonifier Cell Disrupter model W140D
(Heat System - Ultrasonics, Inc.).

The cell suspension was

sonified at 35 to 45 watts for 4 minutes in a 25 ml capacity
sonicating flask suspended in an iced brine bath.

The

sonicated material was then allowed to cool for five minutes
after which the procedure was repeated.

After the second

disruption of the cells, the material was separated into
centrifuge tubes and centrifuged at 13,000 x g for 15 minutes
at 0-4°C.

The supernatant (S-13 fraction) was decanted and

stored at -10°C for 1 h and subsequently stored at -70°C
until used for experimentation.
The anaerobic bacteria Bacteroides fragilis and
Clostridium perfringens were prepared by inoculating 25 ml
BHI broth in test tubes from the stock cultures.

These

tubes were incubated anaerobically in Gas Pak jars (BBL
Microbiology Systems, Cockeyeville, MD) at 37°C for 16-18 h.
Just prior to removal of the cultures from the anaerobe jar,
several 1-L flasks containing 650 ml of BHI broth were
heated to 100°C (boiling) to drive off the dissolved oxygen
present in the medium and then rapidly cooled to 25-30°C in
an ice bath.
Following this procedure, the cultures were removed
from the jars, and 50 ml of the broth culture in the tubes
were carefully pipetted to the bottom of the 1-L screw-cap
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flasks.

These were then tightly sealed and placed in 37°C

incubator for 18 to 24 h.

The flasks were then carefully

moved to a 0-4°C refrigerator to cool for several hours.
From this point on the procedure for obtaining the S-13
fraction was identical as described for the aerobic bacterial
cultures.

Microbial Homogenates (S-100)
The S-100 homogenates were prepared from the S-13
preparations.

The 5-13 fluid was decanted into centrifuge

tubes and centrifuged at 100,000 x g for 1 h at 0-4°C in a
IBC preparative ultracentrifuge.

Both the supernatant and

the resulting pellet were retained.

The supernatant was

carefully removed with a pipette; the pellet was re-suspended
in an equivalent amount of the 0.15 M KC1 solution.

Both

were stored in the same manner as the 5-9 and S-13.

The S-100

was distinguished from the re-suspended pellet by referring
to the pellet as membrane-bound enzyme mixutre.

Chemicals
AROCLOR 1254 was from Aldrich Chemical Co.

It was

prepared by transferring 1 g to a rubber stoppered vial
containing 5 ml of pure olive oil (Pompeii).
The positive control carcinogen, 2-aminoanthracene
(Sigma Chemical Co.), was dissolved in dimethylsulfoxide
(Sigma Chemical Co.).
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To

Agar
g of NaC1
The top agar was prepared by dissolving 5

d water.
and 6 g of agar (Difeo) in 1 ml of distille

Before

kly supplemented with
using, molten top agar at 45°C was quic
HC1 - 0.5 mM biotin,
a sterile solution of 0.5 mM L-histidine
d minimal agar with 2%
the contents mixed, and poured on soli
glucose.
1.5% agar (Difco)
The minimal-glucose agar consisted of
in Vogel-Bonner Medium E with 2% glucose.

When properly

ed into sterile petri
tempered, 20 ml of the medium were pour
plates (100 x 15 mm, Falcon Plastics).
ormed as
The plate incorporation assays were perf
some modifications.
described by Ames et al. (1975b) with
inoculated with the
Tubes containing 24 ml of BHI broth were
TA-100 from refrigtester strains S. typhimurium TA-98 and
erator working cultures.

The cells were grown in a shaker

0 h (TA-100) at 37°C.
incubator for 16-18 h (TA-98) and 24-3
strain was added to top
A 0.1 ml aliquot of bacterial tester
inoanthracene and 0.5
agar at 50°C followed by 0.1 ml of 2-am
upon the enzyme
ml of the S-9, S-13 or S-100, depending
system being tested.

ed
The contents were mixed and pour

on minimal glucose agar plates.

Duplicate plates were poured

were repeated at
for each experiment, and the experiments
least two times.
ared, they were
After all plates had been properly prep
starting at the
incubated for 24 h at 37°C with the time
completion of the last assay plate.

At this time a few
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representative plates were removed from the incubator and
examined to assure a confluent background growth.

The

plates were then returned to the darkened incubator to be
incubated for an additional 24 h after which the revertant
colonies were counted.

Any plate that had a twofold colony

count increase over the negative control plates were considered to be positive, indicating that the test chemical
was mutagenic and the enzyme activation system was properly
functioning.
All plates were then incubated for an additional 24 h,
and the control plates and any negative or borderline
negative or positive plates were recounted to assure as
much accuracy as possible.

Never in the experiments did the

negative control show a significant variation between the
48 h and 72 h counts.

RESULTS AND DISCUSSION

Testing of Enzyme Preparations from Microorganisms
The plate incorporation assay was performed as
previously described using S-9 as a control and testing
S-13 enzymatic preparations to determine if they would
activate the precarcinogen.

Ames et al. (1975) noted that

for optimum mutagenesis with a compound the amount of S-9
added per plate is critical.

Thus, the optimum amount of

S-13 was also tested for optimum mutagenesis from each
microorganism.

Any of the S-I3 preparations that failed

to show a twofold increase in reverse mutants over the
controls, indicative of the positive response, were termed
negative, and testing of that enzyme preparation was
discontinued.
Revertant colony numbers for the two tester strains
with three different concentrations of S-13 from S.
faecalis are presented in Fig. 1.

The positive response

did occur and the optimal concentration of S-13 was 100 pl.
As shown in Table 1, the optimal concentration is equivalent
to 0.714 mg of protein per plate.
Revertant colony numbers for the two tester strains
with three concentrations of S-13 from E. coil are presented
in Fig. 2.

The response was negative.

It should be noted

that the average number of reverse mutants on the control
plates was greater as compared to the enzyme preparations
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Figure 1.

Optimal concentration of the Streptococcus
faecalis enzyme preparation.
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Figure 2.

Optimal concentration of the Escherichia coli
enzyme preparation.
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Table 1.

Milligrams of Protein per Assay Plate of
Active Microbial S-13 Preparations.

Salmonella typhimurium mutants
S-13 Preparation*

TA-98

TA-100

Streptococcus
faecalis

0.714 mg/plate

0.714 mg/plate

Clostridium
perfringens

1.37 mg/plate

1.37 mg/plate

Pseudomonas
aeruginosa

2.44 mg/plate

1.63 mg/plate

Candida
albicans

0.255 ma/plate

0.255 mg/plate

*Enzyme preparation after centrifugation at 13,000 x g
(See Materials and Methods).
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from the other microorganisms.

This increase in back

mutations in the controls could affect the determination of
a positive response.

This increase in back mutations in

the control could make the zero for mutations high thereby
causing a false negative.
Revertant colony numbers for the two tester strains
with three concentrations of S-13 from P. aeruginosa are
shown in Fig. 3.

Unlike any of the enzymes from the other

microorganisms tested, P. aeruginosa showed different
optimal concentrations for each of the tester strains of
S. typhimurium.
response.

S. typhimurium TA-100 gave the best

Table 1 shows that the enzymatic preparation from

P. aeruginosa required the highest amount of protein per
plate for both tester strains of S. typhimurium as compared
to enzyme preparations from the other tested microorganisms
giving a positive response.
Revertant colony numbers for the two tester strains
with three concentrations of S-13 from B. fragilis are
presented in Fig. 4.

The response demonsrated by this

figure was negative.

Unlike S-13 prepared from E. coli,

B. fragilis S-13 system did not increase the number of
back mutations for the tester strains in the control plates.
Although the S-13 preparation from this bacterium did
demonstrate a peak of 100 ul of enzyme preparation, this
peak was well below the twofold increase necessary for
designation as a positive response.
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Figure 3.
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Optimal concentration of the Bacteroides
fragilis enzyme preparation.
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Revertant colony numbers for the two tester strains
witil three concentrations of S-13 from C. prfringens are
7resented in Fig. 5.

It can be observed that a positive

1:e!,Iponse occurred and that the optimum concentration of the
enzyme preparation was 100 pl. for both tester strains.

As

shown in Table 1 the protein concentration necessary for
optimal activation of the precarcinogen was approximately
twice the amount necessary from S. faecalis and less than
the amount necessary for the enzyme preparation from P.
aeruginosa.
Revertant colony numbers for the two tester strains
with three concentrations of S-13 from the eukaryote C.
albicans are presented in Fig. 6.

This figure clearly

demonstrates that the response was positive with 50 01 of
the enzyme preparation.

As shown in Table 1 the protein

concentration in the enzyme preparation from this yeast
was less than one-half the protein needed for activation
from the enzymic preparations from the prokaryotic bacteria.
Dose-Response Curves for 2-aminoanthracene Using S-13
Preparations
Revertant colony numbers for the two tester strains
tested with the precarcinogen at six different doses using
S-13 preparation from C. albicans are presented in Fig. 7.
Shown is a response similar to those seen with mammalian
enzymes when S. typhimurium TA-98 was used as the tester
strain (Ames et al. 1975).

As both enzyme preparations are
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Figure 5.
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Figure 6.

Optimal concentration of the Candida albicans
enzyme preparation.

TA-98 TEST

REVERTANTS/PLATE MINUS CONTROL

TA-100 TEST
mamma..•

•

•

•

TA-98 CONTROL
TA-100 CONTROL

amome••••

•

•

50

•

100

JJG OF ENZYME PREPARATION

•

•

150

21

Figure 7.

Linear dose-response of 2-aminoanthracene using
Candida albicans enzymes for activation with
Salmonella TA-98 and TA-100.
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from eukaryotic cells, it is not unexpected that these
curves would be similar.

However, when S. .typhimurium

tester strain TA-100 was used, the response was not as
finely defined as the response demonstrated by TA-98, but
it still has the same basic shape when graphed.
Revertant colony numbers for the two tester strains
tested with 2-aminoanthracene at six different doses using
S-13 preparation from S. faecalis are presented in Fig. 8.
As noted in Fig. 8, tester strain TA-98 demonstrated a
decrease after an initial increase and then a second
increase followed by the usual decline in response associated
with the higher concentration of a carcinogen/mutagen as it
becomes cytotoxic.

A possible reason for the unexpected

decline in response suggests there are competing enzyme
systems present in this S-13 preparation for activation of
2-aminoanthracene.

As can be seen in Fig. 8, tester strain

TA-100 did not demonstrate this response.
Revertant colony numbers for the two tester strains
tested with 2-aminoanthracene at six different doses using
S-13 preparations from C. perfringens are presented in
Fig. 9.

Enzymic preparations produced at least two peaks

with both tester strains as noted with the enzymic preparation from S. faecalis tested with tester strain TA-98
(Fig. 8).

Again, the competition of enzyme systems from

C. perfringens could account for the pattern evidenced in
the figures.
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Figure 8.

The linear dose-response of 2-aminoanthracene
using Streptococcus faecalis enzymes for
activation uirth Salmonella TA-98 and TA-100.
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Figure 9.

Linear dose-response of 2-aminoanthracene
using Clostridium pefringens for activation
with Salmonella TA-98 and TA-100.
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Revertant colony numbers for the two tester strains
tested with 2-aminoanthracene at six different doses using
S-13 preparation from P. aeruginosa are shown in Fig. 10.
The 5-13 preparation from P. aeruginosa caused the chemical
to produce the largest number of reverse mutants as compared
to the S-13 preparation from the other microorganisms.

It

should be noted that at a concentration of 40 pg of 2aminoanthracene the TA-100 tester strain background "lawn"
was reduced, and therefore information is not reported for
this point on the figure.

Dose-Response Curves for 2-aminoanthracene Using S-100
Preparation
In an attempt to locate the site of the activating
enzymes, activation by S-100 and the membrane pellet obtained
during preparation of the S-100 fraction was compared.

The

comparisons were performed on only those microbial extracts
which exhibited activation.
Revertant colony numbers for the two tester strains
tested with 2-aminoanthracene at three different doses using
5-100 (cytosolic) and the membrane pellet from C. albicans
are shown in Fig. 11.

Since the membrane-bound enzymes

demonstrated a negative response, this data is not shown.
Thus, it appears that activation is due to the cytosolic
enzymes as demonstrated with both S. typhimurium tester
strains.
Revertant colony numbers for the two tester strains
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Figure 10.

Linear dose-response of 2-aminoanthracene
using Pseudomonas aeruginosa enzymes for
activation with Salmonella TA-98 and
TA-100.
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Figure 11.

The activation of 2-aminoanthracene using
Candida albicans cytosolic enzymes for
activation with Salmonella TA-98 and
TA-100.
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tested with 2-aminoanthracene at three different doses
using S-100 and the membrane pellet from S. faecalis are
shown in Fig. 12.

This data demonstrates that the decline

in activation reported previously is not due to competition
between membrane-bound enzymes and cytosolic enzymes for
activation sites but may be due to some other activity of
the enzymes from the cytosol or membranes, since the decline
in activation was not observed when the two enzyme systems
were separated.
Revertant colony numbers for the two tester strains
tested with 2-aminoanthracene at three different doses using
S-100 and the membrane pellet from C. perfringens are shown
in Fig. 13.

This data demonstrates that the membrane-bound

enzymes of C. perfringens resulted in activation of 2aminoanthracene and the cytosolic enzymes showed activation.
Revertant colony numbers for the two tester strains
tested with 2-aminoanthracene at three different doses using
5-100 and the membrane pellet from P. aeruginosa are shown
in Fig. 14.

Both tester strains showed activation with

cytosolic enzymes but failed to show activation with the
membrane-bound enzymes.
In conclusion, the results of this research have
demonstrated that microbial enzyme systems can replace
mammalian enzyme systems in the Ames assay.

Of the six

organisms that can he isolated from the human intestinal
tract and tested, four had sufficient enzyme systems to
activate the precarcinogen 2-aminoanthracene to its
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Figure 12.

The activation of 2-aminoanthracene comparing
Streptococcus faecalis membrane -bound versus
cytosolic enzymes.

REVERTANTS KEY:
CYTOSOL TA -98
CYTOSOL TA-100
ME M BRANE TA-98
MEMBRANE TA-100

••••••••• • 41•••••••••• • M••••••••••••••

•••• aft

=roam

REVERTANTS/PLATE M NUS CONTROL

3001

mO.

•

•

I

0..."--•••• •
•

4

5

10

JJG OF EN ZYMk EBEPARATIPN

15

30

Figure 13.

The activation of 2-aminoanthracene comparing
membrane bound versus cytosolic enzymes of
Clostridium perfringens.
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Figure 14.

The activation of 2aminoanthracene
comparing membrane-b
ound versus cytosoli
c
enzymes of Pseudomona
s aeruginosa.
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mutagenic potential.

It is interesting that two of the

bacteria tested are considered to be indigenous flora of
the human intestinal tract did not activate 2-aminoanthracene.
It is possible that E. coli and B. fragilis do not possess
cytochrome P450 or equivalent which is necessary for
activation in mammalian systems (Bjorkhem et al. 1976).
Four microorganisms tested, that can be isolated from
the human intestinal tract, had proper enzyme systems to
activate the precarcinogen 2-aminoanthracene to its mutagenic potential.

Of these S. faecalis and C. perfringens

are considered indigenous flora of the human intestinal
tract.

These bacteria certainly might be part of the

"fecalases" which Tamura et al. (1980) demonstrated in
feces which activated glycosides to mutagens.

More signi-

ficantly is, this research demonstrated that S. faecalis,
P. aeruginosa, C. perfringens and Candida albicans activate
2-aminoanthracene to its mutagenic potential without the
mammalian liver homogenate.

Thus, if this chemical were

ingested, intestinal microorganisms could convert it to
a mutagen.

Whether this reaction would actually happen in

vivo has not been tested.

Research similar to that presented

in this thesis was done by Chug et al. (1981).

They

demonstrated that Fusobacterium spp. converted methyl yellow
to N,N-demethyl-p-phenylenediamine which was metabolically
activated to a mutagen.
Epidemiological studies suggest that cancer in human
populations results from environmental factors particularly
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the diet (Doll, 1977; Hoover and Fraumeni, 1975; and Sinha
and Paruleka, 1983).

Possibly, certain microflora of the

intestinal tract are converting chemicals from the diet
into carcinogens.

The work presented here could possibly

lead to the understanding of the cause of colon cancer
and its cure.
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